MIXTARD HUMAN

Mixtard Human Adverse Events Reported to the FDA Over Time

How are Mixtard Human adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Mixtard Human, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Mixtard Human is flagged as the suspect drug causing the adverse event.

Most Common Mixtard Human Adverse Events Reported to the FDA

What are the most common Mixtard Human adverse events reported to the FDA?

Hypoglycaemia	35 (4.32%)
Intentional Drug Misuse	30 (3.7%)
Homicide	25 (3.09%)
Blood Glucose Increased	21 (2.59%)
Victim Of Homicide	16 (1.98%)
Death	14 (1.73%)
Dyspnoea	12 (1.48%)
Fall	11 (1.36%)
Vomiting	10 (1.23%)
Blood Insulin Increased	9 (1.11%)
Hypoglycaemic Coma	9 (1.11%)
	Show More
Physical Assault	9 (1.11%)
Suicide Attempt	9 (1.11%)
Eye Swelling	8 (.99%)
Hot Flush	8 (.99%)
Hyperglycaemia	8 (.99%)
Orthostatic Hypotension	8 (.99%)
Pruritus	8 (.99%)
Abdominal Pain Upper	7 (.86%)
Convulsion	7 (.86%)
Erythema	7 (.86%)
Loss Of Consciousness	7 (.86%)
Pneumonia	7 (.86%)
Product Quality Issue	7 (.86%)
Victim Of Crime	7 (.86%)
Aphasia	6 (.74%)
Blood Creatinine Increased	6 (.74%)
Blood Glucose Decreased	6 (.74%)
Chest Pain	6 (.74%)
Device Leakage	6 (.74%)
Diabetic Ketoacidosis	6 (.74%)
Hyperparathyroidism Primary	6 (.74%)
Injection Site Erythema	6 (.74%)
Injection Site Rash	6 (.74%)
Parathyroid Tumour Benign	6 (.74%)
Pulmonary Oedema	6 (.74%)
Renal Disorder	6 (.74%)
Renal Failure	6 (.74%)
Adverse Event	5 (.62%)
Coma	5 (.62%)
Confusional State	5 (.62%)
Device Malfunction	5 (.62%)
Myocardial Infarction	5 (.62%)
Nausea	5 (.62%)
Overdose	5 (.62%)
Renal Failure Acute	5 (.62%)
Syncope	5 (.62%)
Victim Of Child Abuse	5 (.62%)
Asthenia	4 (.49%)
Blood Urea Increased	4 (.49%)
Burning Sensation	4 (.49%)
Cardiac Arrest	4 (.49%)
Cerebrovascular Accident	4 (.49%)
Chills	4 (.49%)
Circulatory Collapse	4 (.49%)
Completed Suicide	4 (.49%)
Dehydration	4 (.49%)
Depressed Level Of Consciousness	4 (.49%)
Dysgeusia	4 (.49%)
Eye Pain	4 (.49%)
Feeling Cold	4 (.49%)
General Physical Health Deteriorati...	4 (.49%)
Hyperhidrosis	4 (.49%)
Hypotension	4 (.49%)
Incorrect Dose Administered	4 (.49%)
Medication Error	4 (.49%)
Pleural Effusion	4 (.49%)
Premature Baby	4 (.49%)
Rash Generalised	4 (.49%)
Arteriovenous Fistula Operation	3 (.37%)
Arteriovenous Fistula Thrombosis	3 (.37%)
Azotaemia	3 (.37%)
Blood Glucose Fluctuation	3 (.37%)
Blood Insulin	3 (.37%)
Cardiac Failure	3 (.37%)
Cerebral Ischaemia	3 (.37%)
Chronic Lymphocytic Leukaemia	3 (.37%)
Drug Ineffective	3 (.37%)
Drug Interaction	3 (.37%)
Enteritis	3 (.37%)
Excoriation	3 (.37%)
Fracture	3 (.37%)
Gastrointestinal Infection	3 (.37%)
Hypersensitivity	3 (.37%)
Intervertebral Disc Disorder	3 (.37%)
Malaise	3 (.37%)
Palpitations	3 (.37%)
Paraesthesia Oral	3 (.37%)
Periorbital Haematoma	3 (.37%)
Pruritus Generalised	3 (.37%)
Pulmonary Fibrosis	3 (.37%)
Pyoderma	3 (.37%)
Respiratory Failure	3 (.37%)
Skin Infection	3 (.37%)
Sudden Death	3 (.37%)
Urticaria	3 (.37%)
Withdrawal Syndrome	3 (.37%)
Abdominal Discomfort	2 (.25%)
Agitation	2 (.25%)
Alcohol Interaction	2 (.25%)
Alcohol Use	2 (.25%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Mixtard Human, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Mixtard Human is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Mixtard Human

What are the most common Mixtard Human adverse events reported to the FDA?

Legal Issues	62 (7.65%)
Neurological	52 (6.42%)
Glucose Metabolism Disorders	50 (6.17%)
Psychiatric	33 (4.07%)
Metabolic, Nutritional And Blood Ga...	30 (3.7%)
Infections - Pathogen Unspecified	29 (3.58%)
Epidermal And Dermal Conditions	26 (3.21%)
Gastrointestinal Signs	25 (3.09%)
Injuries	24 (2.96%)
Renal Disorders	21 (2.59%)
Fatal Outcomes	19 (2.35%)
	Show More
Procedural And Device Related Injur...	19 (2.35%)
Medication Errors	18 (2.22%)
Respiratory	18 (2.22%)
Administration Site Reactions	17 (2.1%)
Decreased And Nonspecific Blood Pre...	16 (1.98%)
Eye	15 (1.85%)
Therapeutic And Nontherapeutic Effe...	15 (1.85%)
Endocrine Investigations	13 (1.6%)
Suicidal And Self-injurious Behavio...	13 (1.6%)
Renal And Urinary Tract Investigati...	12 (1.48%)
Lower Respiratory Tract Disorders	11 (1.36%)
Seizures	9 (1.11%)
Bone And Joint Injuries	8 (.99%)
Cardiac Arrhythmias	8 (.99%)
Central Nervous System Vascular	8 (.99%)
Diabetic Complications	8 (.99%)
Vascular	8 (.99%)
Deliria	7 (.86%)
Electrolyte And Fluid Balance Condi...	7 (.86%)
Product Quality Issues	7 (.86%)
Coronary Artery	6 (.74%)
Endocrine Neoplasms Benign	6 (.74%)
Oral Soft Tissue Conditions	6 (.74%)
Parathyroid Gland	6 (.74%)
Bone And Joint Therapeutic Procedur...	5 (.62%)
Cardiac And Vascular Investigations	5 (.62%)
Cardiac Disorder Signs	5 (.62%)
Angiedema And Urticaria	4 (.49%)
Anxiety Disorders	4 (.49%)
Bacterial Infectious	4 (.49%)
Gastrointestinal Motility And Defec...	4 (.49%)
Heart Failures	4 (.49%)
Neonatal And Perinatal Conditions	4 (.49%)
Pleural	4 (.49%)
Skin Appendage Conditions	4 (.49%)
Therapeutic Procedures And Supporti...	4 (.49%)
Allergic Conditions	3 (.37%)
Chemical Injury And Poisoning	3 (.37%)
Gastrointestinal Inflammatory Condi...	3 (.37%)
Gastrointestinal Ulceration And Per...	3 (.37%)
Leukemias	3 (.37%)
Musculoskeletal And Connective Tiss...	3 (.37%)
Obstetric And Gynecological Therape...	3 (.37%)
Skin And Subcutaneous Tissue	3 (.37%)
Vascular Therapeutic Procedures	3 (.37%)
Abortions And Stillbirth	2 (.25%)
Appetite And General Nutritional	2 (.25%)
Body Temperature Conditions	2 (.25%)
Bone Disorders	2 (.25%)
Hematological And Lymphoid Tissue T...	2 (.25%)
Hematology Investigations	2 (.25%)
Joint	2 (.25%)
Lifestyle Issues	2 (.25%)
Musculoskeletal And Connective Tiss...	2 (.25%)
Pregnancy, Labour, Delivery And Pos...	2 (.25%)
Protein And Chemistry Analyses	2 (.25%)
Tissue	2 (.25%)
Vascular Hemorrhagic	2 (.25%)
Vascular Hypertensive	2 (.25%)
Vision	2 (.25%)
Water, Electrolyte And Mineral	2 (.25%)
Acid-base	1 (.12%)
Ancillary Infectious Topics	1 (.12%)
Anemias Nonhemolytic And Marrow Dep...	1 (.12%)
Arteriosclerosis, Stenosis, Vascula...	1 (.12%)
Bone, Calcium, Magnesium And Phosph...	1 (.12%)
Changes In Physical Activity	1 (.12%)
Disturbances In Thinking	1 (.12%)
Exocrine Pancreas Conditions	1 (.12%)
Gastrointestinal Conditions	1 (.12%)
Gastrointestinal Neoplasms Malignan...	1 (.12%)
Gastrointestinal Therapeutic Proced...	1 (.12%)
Headaches	1 (.12%)
Immune	1 (.12%)
Increased Intracranial Pressure And...	1 (.12%)
Miscellaneous And Site Unspecified ...	1 (.12%)
Movement Disorders	1 (.12%)
Muscle	1 (.12%)
Myocardial	1 (.12%)
Nervous System Neoplasms Malignant ...	1 (.12%)
Neurological Disorders Congenital	1 (.12%)
Ocular Hemorrhages And Vascular	1 (.12%)
Ocular Infections, Irritations And ...	1 (.12%)
Ocular Structural Change, Deposit A...	1 (.12%)
Renal And Urinary Tract Therapeutic...	1 (.12%)
Retina, Choroid And Vitreous Hemorr...	1 (.12%)
Structural Brain	1 (.12%)
Tendon, Ligament And Cartilage	1 (.12%)
Toxicology And Therapeutic Drug Mon...	1 (.12%)
Urinary Tract Signs	1 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Mixtard Human, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Mixtard Human is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.